166 related articles for article (PubMed ID: 17606719)
1. Prognostic significance of the immunohistochemical staining of cleaved caspase-3, an activated form of caspase-3, in gliomas.
Kobayashi T; Masumoto J; Tada T; Nomiyama T; Hongo K; Nakayama J
Clin Cancer Res; 2007 Jul; 13(13):3868-74. PubMed ID: 17606719
[TBL] [Abstract][Full Text] [Related]
2. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
3. Expression pattern and clinical prognostic relevance of bone morphogenetic protein-2 in human gliomas.
Liu C; Tian G; Tu Y; Fu J; Lan C; Wu N
Jpn J Clin Oncol; 2009 Oct; 39(10):625-31. PubMed ID: 19797419
[TBL] [Abstract][Full Text] [Related]
4. Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in human gliomas is associated with unfavorable overall survival.
Ding L; Sun X; You Y; Liu N; Fu Z
Transl Res; 2010 Jul; 156(1):45-52. PubMed ID: 20621036
[TBL] [Abstract][Full Text] [Related]
5. Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis.
Shen A; Wang Y; Zhao Y; Zou L; Sun L; Cheng C
Neurosurgery; 2009 Jul; 65(1):153-9; discussion 159-60. PubMed ID: 19574837
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of p53 immunoreactivity in patients with glioma.
Kyritsis AP; Bondy ML; Hess KR; Cunningham JE; Zhu D; Amos CJ; Yung WK; Levin VA; Bruner JM
Clin Cancer Res; 1995 Dec; 1(12):1617-22. PubMed ID: 9815964
[TBL] [Abstract][Full Text] [Related]
7. [Expression of SV40Tag, Rb and IRS-1 in glioma detected by tissue microarray and their relation with tumorigenesis and progression of gliomas].
Qian ZY; Wu YY; Huang Q; Zhai DZ; Zhu Q; Wang AD; Huo HM; Lan Q
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):432-6. PubMed ID: 19024517
[TBL] [Abstract][Full Text] [Related]
8. Glycosphingolipid component profiles or human gliomas--correlation to survival time and histopathological malignancy grading.
Becker R; Rohlfs J; Jennemann R; Wiegandt H; Mennel HD; Bauer BL
Clin Neuropathol; 2000; 19(3):119-25. PubMed ID: 14606584
[TBL] [Abstract][Full Text] [Related]
9. Gamma-ray mutagen sensitivity and survival in patients with glioma.
Sigurdson AJ; Bondy ML; Hess KR; Toms SA; Kyritsis AP; Gu J; Wang LE; Wang X; Adatto P; Bruner JL; Yung WK; Levin VA; Wei Q
Clin Cancer Res; 1998 Dec; 4(12):3031-5. PubMed ID: 9865917
[TBL] [Abstract][Full Text] [Related]
10. Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma.
Söling A; Sackewitz M; Volkmar M; Schaarschmidt D; Jacob R; Holzhausen HJ; Rainov NG
Clin Cancer Res; 2005 Jan; 11(1):249-58. PubMed ID: 15671553
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of matrix metalloproteinase-1 and proteinase-activated receptor-1 promotes the progression of human gliomas.
Zhang Y; Zhan H; Xu W; Yuan Z; Lu P; Zhan L; Li Q
Pathol Res Pract; 2011 Jan; 207(1):24-9. PubMed ID: 21087829
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of neuroepithelial-transforming protein 1 confers poor prognosis of patients with gliomas.
Tu Y; Lu J; Fu J; Cao Y; Fu G; Kang R; Tian X; Wang B
Jpn J Clin Oncol; 2010 May; 40(5):388-94. PubMed ID: 20304779
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic significance of cystatin C expression in gliomas.
Nakabayashi H; Hara M; Shimuzu K
Hum Pathol; 2005 Sep; 36(9):1008-15. PubMed ID: 16153465
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between the expression of O6-methylguanine-DNA methyltransferase in glioma and the survival time of patients].
Sun YH; Zhang YZ; Wang ZC; Sun MZ; Zhao DH
Ai Zheng; 2004 Sep; 23(9):1052-5. PubMed ID: 15363200
[TBL] [Abstract][Full Text] [Related]
15. Long-term prognostic assessment of 185 newly diagnosed gliomas: Grade III glioma showed prognosis comparable to that of Grade II glioma.
Shinohara C; Muragaki Y; Maruyama T; Shimizu S; Tanaka M; Kubota Y; Oikawa M; Nakamura R; Iseki H; Kubo O; Takakura K; Hori T
Jpn J Clin Oncol; 2008 Nov; 38(11):730-3. PubMed ID: 18820008
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
[TBL] [Abstract][Full Text] [Related]
17. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
[TBL] [Abstract][Full Text] [Related]
18. IQGAP1 and IGFBP2: valuable biomarkers for determining prognosis in glioma patients.
McDonald KL; O'Sullivan MG; Parkinson JF; Shaw JM; Payne CA; Brewer JM; Young L; Reader DJ; Wheeler HT; Cook RJ; Biggs MT; Little NS; Teo C; Stone G; Robinson BG
J Neuropathol Exp Neurol; 2007 May; 66(5):405-17. PubMed ID: 17483698
[TBL] [Abstract][Full Text] [Related]
19. A multivariate analysis of the prognostic factors of grade III gliomas.
Zhu YJ; Zhu XD; Wang SH; Shen F; Shen H; Liu WG
Chin Med J (Engl); 2008 Jun; 121(12):1072-5. PubMed ID: 18706219
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin D is a potential serum marker for poor prognosis in glioma patients.
Fukuda ME; Iwadate Y; Machida T; Hiwasa T; Nimura Y; Nagai Y; Takiguchi M; Tanzawa H; Yamaura A; Seki N
Cancer Res; 2005 Jun; 65(12):5190-4. PubMed ID: 15958563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
